tech_banner
Adipogen/SUMO Conjugation Negative Control Peptide Substrate (Biotin)/AG-CP3-0020-C020/20 µg
More Information Product Details Synonyms Product Type Properties MW Purity Chemicals Appearance Solubility Formulation Crossreactivity Declaration Other Product Data Shipping and Handling Shipping Short Term Storage Long Term Storage Handling Advice Use/Stability Documents MSDS Product Specification Sheet Datasheet
Small Ubiquitin-like Modifiers Negative Control Peptide Substrate
Chemical
1.53kDa
≥90% (HPLC)
White lyophilized powder.
Soluble in water or other aqueous buffers (5mg/ml).
Lyophilized from a 0.2 μm filtered solution in Acetic Acid.
Multi-species
Manufactured by Boston Biochem
Use: Negative control and contains a scrambled version of the consensus motif sequence. It will not be conjugated to SUMO-1, SUMO-2 or SUMO-3 proteins in the presence of the E1 activating (SAE1/SAE2) and UbcH9 conjugating enzymes. The biotin group allows for sensitive and convenient detection using avidin-linked reagents. Add stock to in vitro or in vivo assays at desired concentration. Recommended concentration range is 50-100μM depending on conditions.
AMBIENT
+4°C
-20°C
Aliquot to avoid freeze/thaw cycles.
Stable for at least 1 year after receipt when stored at -20°C.
Download PDF
Download PDF
Small ubiquitin-like Modifiers (SUMOs) are a family of small, related proteins that can be enzymatically attached to a target protein by a post-translational modification process termed SUMOylation. There are four known SUMOs (SUMO1-4). All SUMO proteins share a conserved ubiquitin domain and a C-terminal diglycine cleavage/attachment site. Following cleavage of a C-terminal prosegment, the C-terminal glycine residue of SUMO is enzymatically attached to a lysine residue on a target protein. In humans, SUMO is conjugated to a variety of molecules in the presence of the SAE1/UBA2 SUMO-activating (E1) enzyme and the UBE2I/Ubc9 SUMO-conjugating (E2) enzyme. In yeast, the SUMO-activating (E1) enzyme is Aos1/Uba2p. SUMOylation can occur without the requirement of a specific SUMO ligase (E3), where SUMO is transferred directly from UBE2I/Ubc9 to specific substrates. Unlike SUMO1, which is usually conjugated to proteins as a monomer, SUMO2 and SUMO3 are known to form high molecular weight polymers on proteins. SUMO precursor processing and deconjugation are catalyzed by a family of cysteine proteases known as SUMO-specific proteases (SENPs) and DeSUMOylating Isopeptidase 1.